Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin delivery

European Journal of Pharmaceutical Sciences - Tập 42 - Trang 445-451 - 2011
Abdallah Makhlof1,2, Yuichi Tozuka1, Hirofumi Takeuchi1
1Laboratory of Pharmaceutical Engineering, Gifu Pharmaceutical University, 1-25-4 Daigaku-nishi, Gifu 501-1196, Japan
2Department of Industrial Pharmacy, Assiut University, Assiut, Egypt

Tài liệu tham khảo

Agnihotri, 2004, Recent advances on chitosan-based micro- and nanoparticles in drug delivery, J. Control. Release, 100, 5, 10.1016/j.jconrel.2004.08.010

Amidi, 2010, Chitosan-based delivery systems for protein therapeutics and antigens, Adv. Drug Deliv. Rev., 62, 59, 10.1016/j.addr.2009.11.009

Atuma, 2001, The adherent gastrointestinal mucus gel layer: thickness and physical state in vivo, Am. J. Physiol. Gastrointest. Liver Physiol., 280, 922, 10.1152/ajpgi.2001.280.5.G922

Bernkop-Schnürch, 1996, Novel bioadhesive drug delivery system protecting (poly)peptides from gastric enzymatic degradation, Int. J. Pharm., 138, 75, 10.1016/0378-5173(96)04532-2

Boonsongrit, 2006, Chitosan drug binding by ionic interaction, Eur. J. Pharm. Biopharm., 62, 267, 10.1016/j.ejpb.2005.09.002

Fernandez-Urrusuno, 1999, Enhancement of nasal absorption of insulin using chitosan nanoparticles, Pharm. Res., 16, 1576, 10.1023/A:1018908705446

Gan, 2005, Modulation of surface charge, particle size and morphological properties of chitosan–TPP nanoparticles intended for gene delivery, Colloids Surf. B, 44, 65, 10.1016/j.colsurfb.2005.06.001

George, 2006, Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan – a review, J. Control. Release, 114, 1, 10.1016/j.jconrel.2006.04.017

Hejazi, 2003, Chitosan-based gastrointestinal delivery systems, J. Control. Release, 89, 151, 10.1016/S0168-3659(03)00126-3

Hennink, 2002, Novel cross-linking methods to design hydrogels, Adv. Drug Deliv. Rev., 54, 13, 10.1016/S0169-409X(01)00240-X

Hombach, 2009, Chitosan solutions and particles: evaluation of their permeation enhancing potential on MDCK cells used as blood brain barrier model, Int. J. Pharm., 376, 104, 10.1016/j.ijpharm.2009.04.027

Huang, 2002, Uptake of FITC-CS nanoparticles by A549 cells, Pharm. Res., 19, 1488, 10.1023/A:1020404615898

Jintapattanakit, 2007, Peroral delivery of insulin using chitosan derivatives. A comparative study of polyelectrolyte nanocomplexes and nanoparticles, Int. J. Pharm., 342, 240, 10.1016/j.ijpharm.2007.05.015

Jung, 2000, Biodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake?, Eur. J. Pharm. Biopharm., 50, 147, 10.1016/S0939-6411(00)00084-9

Kaarsholm, 1990, Ionization behavior of native and mutant insulins: pK perturbation of B13-Glu in aggregated species, Arch. Biochem. Biophys., 283, 496, 10.1016/0003-9861(90)90673-M

Kean, 2010, Biodegradation, biodistribution and toxicity of chitosan, Adv. Drug Deliv. Rev., 62, 3, 10.1016/j.addr.2009.09.004

Khafagy, 2007, Current challenges in non-invasive insulin delivery systems: a comparative review, Adv. Drug Deliv. Rev., 59, 1521, 10.1016/j.addr.2007.08.019

Kokubo, 1997, Development of cellulose derivatives as novel enteric coating agents soluble at pH 3.5–4.5 and higher, Chem. Pharm. Bull., 45, 1350, 10.1248/cpb.45.1350

Lin, 2007, Preparation and characterization of nanoparticles shelled with chitosan for oral insulin delivery, Biomacromolecules, 8, 146, 10.1021/bm0607776

Ma, 2005, Pharmacological activity of peroral chitosan–insulin nanoparticles in diabetic rats, Int. J. Pharm., 293, 271, 10.1016/j.ijpharm.2004.12.025

Ma, 2002, Formulation pH modulates the interaction of insulin with chitosan nanoparticles, J. Pharm. Sci., 91, 1396, 10.1002/jps.10149

Makhlof, 2010, Nanoparticles of glycol chitosan and its thiolated derivative significantly improved the pulmonary delivery of calcitonin, Int. J. Pharm., 397, 92, 10.1016/j.ijpharm.2010.07.001

McConnell, 2008, Gut instincts: explorations in intestinal physiology and drug delivery, Int. J. Pharm., 364, 213, 10.1016/j.ijpharm.2008.05.012

Pan, 2002, Bioadhesive polysaccharide in protein delivery system: chitosan nanoparticles improve the intestinal absorption of insulin in vivo, Int. J. Pharm., 249, 139, 10.1016/S0378-5173(02)00486-6

Peppas, 2004, Devices based on intelligent biopolymers for oral protein delivery, Int. J. Pharm., 277, 11, 10.1016/j.ijpharm.2003.03.001

Qaqish, 1999, Synthesis of a fluorescent chitosan derivative and its application for the study of chitosan–mucin interactions, Carbohyd. Polym., 51, 667

Saarinen-Savolainen, 1997, Method for evaluating drug release from liposomes in sink conditions, Int. J. Pharm., 159, 27, 10.1016/S0378-5173(97)00264-0

Takeuchi, 2005, Effectiveness of submicron-sized, chitosan-coated liposomes in oral administration of peptide drugs, Int. J. Pharm., 303, 160, 10.1016/j.ijpharm.2005.06.028

Thongborisute, 2006, The effect of particle structure of chitosan-coated liposomes and type of chitosan on oral delivery of calcitonin, J. Drug Target., 14, 147, 10.1080/10611860600648346

Vllasaliu, 2010, Tight junction modulation by chitosan nanoparticles: comparison with chitosan solution, Int. J. Pharm., 400, 183, 10.1016/j.ijpharm.2010.08.020

Werle, 2006, The potential of cystine-knot microproteins as novel pharmacophoric scaffolds in oral peptide drug delivery, J. Drug Target., 14, 137, 10.1080/10611860600648254

Thông tin
Thông tin xuất bản

European Journal of Pharmaceutical Sciences

Tập 42

445-451

Thông tin tác giả